MS, A., AR, A., & HA, F. (2024). Novel therapeutic effects of rifaximin in combination with methylprednisolone for LPS-induced oxidative stress and inflammation in mice: An in vivo study. Toxicology reports, 13, 101808. https://doi.org/10.1016/j.toxrep.2024.101808
Chicago Style (17th ed.) CitationMS, Al-Naimi, Abu-Raghif AR, and Fawzi HA. "Novel Therapeutic Effects of Rifaximin in Combination with Methylprednisolone for LPS-induced oxidative Stress and Inflammation in Mice: An in Vivo Study." Toxicology Reports 13 (2024): 101808. https://doi.org/10.1016/j.toxrep.2024.101808.
MLA (9th ed.) CitationMS, Al-Naimi, et al. "Novel Therapeutic Effects of Rifaximin in Combination with Methylprednisolone for LPS-induced oxidative Stress and Inflammation in Mice: An in Vivo Study." Toxicology Reports, vol. 13, 2024, p. 101808, https://doi.org/10.1016/j.toxrep.2024.101808.